316
Views
30
CrossRef citations to date
0
Altmetric
Ketamine Use

Near-Death States Reported in a Sample of 50 Misusers

&
Pages 916-924 | Published online: 23 Apr 2010

References

  • Bell, R., Dahl, J., Moore, R., Kalso, E. (2006). Perioperative ketamine for acute postoperative pain. Emergency Medicine Australasia, 18:37–44.
  • Blanke, O., Ortigue, S., Landis, T., Seeck, M. (2002). Stimulating illusory own-body perceptions. Nature, 419:269–270.
  • Bonta, I. L. (2003). Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptor. Medical Hypotheses, 62:23–28.
  • Comer, N. L., Madow, L., Dizon, J. L. (1967). Observation of sensory deprivation in a life-threatening situation. American Journal of Psychiatry, 124:164–169.
  • Corazza, O. (2008). Near-death experiences: exploring the mind-body connection. London: Routledge.
  • Drugscope. (2005). Annual report. Available from: http://www.drugscope.org.uk (accessed January 4, 2006).
  • Fenwick, P. (1997). Is the near-death experience only N-methyl-d-aspartate blocking? Journal of Near-Death Studies, 16:43–53.
  • French, C. (2005). Near-Death experiences in cardiac arrest survivals. Progress in Brain Research, 150:351–367.
  • Green, S. M., Clem, K. J., Rothroc, K. S. G. (1996). Ketamine safety profile in the developing world: survey of practitioners. Academy and Emergency Medicine, 3:598–604.
  • Greyson, B. (1983). The Near-Death Experience Scale: construction, reliability, and validity. Journal of Nervous Mental Disease, 171:369–375.
  • Greyson, B., Stevenson, I. (1980). The phenomenology of the Near-Death Experience. American Journal of Psychiatry, 137:1193–1196.
  • Jansen, K. L. R. (1989). Near-Death Experiences and the NMDA receptor. British Medical Journal, 298:1708.
  • Jansen, K. L. R. (2001). Ketamine: dreams and realities. Sarasota, Florida: MAPS.
  • Krippendorf, K. (2004). Content Analysis: an introduction to its methodology. 2nd edition, Thousand Oaks, CA: Sage.
  • McCambridge, J., Winstock, A., Hunt, N. (2007). 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European Addiction Research, 13:57–64.
  • Moody, R. A. (1975). Life after life. Atlanta, Georgia: Mockingbird Books.
  • Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L., Curran, V. (2004a). Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study. Psychopharmacology (Berlin), 172:298–308.
  • Morgan, C. J. A., Mofeez, A., Brandner, B., Lesley, B., Curran, V. (2004b). Acute effects of ketamine in memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology, 29:208–218.
  • Morgan, C. J. A., Monaghan, L., Curran, V. (2004c). Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction, 99:1450–1461.
  • Parnia, S., Waller, D. G., Yeates, R., Fenwick, P. (2001) A qualitative and quantitative study of the incidence, features and aetiology of near-death experiences in cardiac arrest survivors. Resuscitation, 48:149–156.
  • Perry, E. B., Jr., Cramer, J. A., Cho, H. S., Petrakis, I. L., Karper, L. P., Genovese, A., (2007). Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology (Berlin), 192:253–260.
  • Persinger, M. (1983). Religious and mystical experiences as artefacts of temporal lobe function: a general hypothesis. Perceptual and Motor Skills, 57:1255–1262.
  • Pomarol-Clotet, E., Honey, G. D., Murray, G. K. (2006). Psychological effects of ketamine in healthy volunteers: phenomenological study. British Journal of Psychiatry, 189:173–179.
  • Schifano, F., Corkery, J., Oyefeso, A., Tonia, T., Ghodse, A. H. (2008). Trapped in the ‘K-hole’; overview of deaths associated with ketamine misuse in the UK (1993–2006). Journal of Clinical Psychopharmacology, 28:114–116.
  • Sehdev, R. S., Symmons, D. A., Kindl, K. (2006). Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emergency Medicine Australasia, 18:37–44.
  • Smith, K. M., Larive, L. L., Romanelli, F. (2002). Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. American Journal of Health-System Pharmacists, 59:1067–1076.
  • van Lommel, P., van Wees, R., Meyers, V., Elfferich, I. (2001). Near-Death experience in survivors of cardiac arrest: a prospective study in the Netherlands. The Lancet, 358:2039–2045.
  • Wolff, K., Winstock, A. R. (2006). Ketamine: from medicine to misuse. CNS Drugs, 20:199–218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.